TickerFacts.

Heartflow, Inc. (HTFL): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

-$59.05M
Year ended 2025-12-31
-$59.18M
Trailing 12 months to 2026-06-30
2023-12-31: -$82.54M2024-12-31: -$73.36M2025-12-31: -$59.05M-$59.05M
2023-12-31 Free Cash Flow (USD) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31-$59.05Mn/m2026-03-18, From 2025-01-01
2024-12-31-$73.36Mn/m2026-03-18, From 2024-01-01
2023-12-31-$82.54Mn/a2026-03-18, From 2023-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
Heartflow, Inc. (HTFL)2025-12-31-$59.05Mn/m
SI-BONE, Inc. (SIBN)2025-12-31-$9.09Mn/m
Neuronetics, Inc. (STIM)2025-12-31-$21.18Mn/m
Treace Medical Concepts, Inc. (TMCI)2025-12-31-$29.49Mn/m
InfuSystem Holdings, Inc (INFU)2025-12-31$23.85M+23.1%
Xtant Medical Holdings, Inc. (XTNT)2025-12-31$10.16Mn/m
Cerus Corp (CERS)2025-12-31$1.11M-87.0%
Orthopediatrics Corp (KIDS)2025-12-31-$15.96Mn/m
Lemaitre Vascular Inc (LMAT)2025-12-31$74.47M+100.4%

Compare HTFL, SIBN, STIM, TMCI side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗